Walter Ludwig Strohmaier

from Wikipedia, the free encyclopedia

Walter Ludwig Strohmaier (born May 27, 1957 in Stuttgart ) is a German urologist and chief physician for urology at the Coburg Clinic , teaching hospital of the University of Split . Strohmaier is a full professor at the University of Split, Croatia and an adjunct professor at the University of Würzburg .

Life

Strohmaier studied human medicine from 1978 to 1983, first at the University of Cologne (until 1980) and then at the University of Tübingen (until 1982). There he joined the Corps Borussia in Tübingen (1977) and Corps Marcomannia Breslau in Cologne (1978). In 1983 he was promoted to Dr. med. PhD. After completing his studies, he completed several stays abroad, for example in 1986 at the University of British Columbia , Vancouver and the University of Toronto as well as at Tel Aviv University and Kyriat Weizmann in Petah Tikva, Israel. From 1983 to 1989 he trained as a urologist at the University of Tübingen's clinic. In 1989 he was appointed senior physician at the Urological Clinic at the University of Tübingen. In 1992 he received his habilitation and was appointed private lecturer at the University of Tübingen. In the same year he passed the European specialist examination and was appointed Fellow of the European Board of Urology (FEBU). Strohmaier has been the chief physician of the Urological Clinic at the Coburg Clinic since 1996. In 1997 he became a visiting professor at the Urological Clinic, Gaziantep University , Turkey. In 1998 he was appointed adjunct professor at the University of Tübingen. He held this professorship until 2007. Since 2007 he has been an adjunct professor at the University of Würzburg . Since 1999, he has also headed neurourology at the Medical Park Bad Rodach rehabilitation clinic. From 2001 to 2016 he was medical director of the Coburg Clinic.

Clinical-scientific contribution

The focus of his scientific work has been in the field of urinary stone research since his dissertation  . He researched all aspects of this disease: In addition to basic experimental research on the pathogenesis of urolithiasis,  he deals with clinical issues relating to the development and prevention of urinary stone disease  . The current focus is on the role of kidney cells in stone formation and the relationship between metabolic syndrome  and urinary stone formation, especially in uric acid stone  . He also deals with instrumental methods of stone removal and has been involved in the development of instruments. He also developed training models for instrumental urinary stone therapy. For many years he has also been working on economic issues related to this disease. In the field of urological  oncology  , he mainly researched the role of  hyperthermia and tumor markers in  prostate cancer  and the immunology of  renal cell carcinoma .

Awards (selection)

  • 1988 Peter Bischoff Prize of the Association of North German Urologists "Excretion of inhibitory substances (citrate, uromucoid, glycosaminoglycans) in renal tubular acidosis"
  • 1992 Scientific Award International Symposium of Urolithiasis Cairns "Protective effects of verapamil on shock wave induced tubular damage"

Memberships (selection)

  • German Society for Urology
  • German continence society
  • European Association of Urology
  • European Urolithiasis Society
  • American Urological Association
  • Societé Internationale d´Urologie
  • International Urolithiasis Society

Functions in specialist societies etc. Ä. (selection)

  • Deputy Chairman of the Urolithiasis Guideline Commission of the German Society for Urology
  • Chairman of the International Urolithiasis Society 2008 - 2018
  • Co-editor of the journal Urological Research / Urolithiasis (Springer Verlag)
  • Member of the editorial board of several specialist journals

Publications

Strohmaier published more than 200 specialist articles and 8 books (as of January 1, 2019)

Books

  • K.-H.Bichler, WLStrohmaier (ed.) (1988): Nephrocalcinosis, Calcium Antagonists and Kidney. Springer Verlag Berlin.
  • K.-H.Bichler, St.H. Flüchter, WLStrohmaier (Ed.) (1988): Therapy of the urinary bladder carcinoma. Springer Verlag Berlin.
  • K.-H.Bichler, WLStrohmaier, DMWilbert (eds.) (1992): Hyperthermia of the prostate. pmi Verlagsgruppe GmbH Frankfurt.
  • K.-H.Bichler, WLStrohmaier, DMWilbert, W.Mattauch (eds.) (1996): Urolithiasis. Attempto Verlag Tübingen.
  • KH.Bichler, D.Wilbert, HWWechsel, WLStrohmaier (1998): Diagnosis and therapy of bladder carcinoma. Einhorn Presse Verlag Reinbek.
  • WLStrohmaier (2002): Care in Urology. Kohlhammer Verlag Stuttgart.
  • K.-H.Bichler, WL Strohmaier, E. Eipper, S. Lahme (2007): The urinary stone disease. Lehmanns Media - LOB Berlin.
  • WLStrohmaier (ed.) (2007): Urolithiasis 2005: Proceedings of the 11th European Symposium on Urolithiasis Coburg. Resch Druck Coburg.

Web links

Individual evidence

  1. ↑ K.- H.BICHLER, C.KIRCHNER, H.WEISER, S.KORN, W.STROHMAIER, P.SCHMITZ-MOORMANN, A.HANCK, HJNELDE (1983) Influence of Vitamin A on the Excretion of Uromucoid and Other Substances in the Urine of Rats Clin. Nephrol. 20, 32-39
  2. ↑ K.-H.BICHLER, WLSTROHMAIER, F.SCHANZ, HJNELDE, I.GAISER, E. SCHULZE, M.SCHREIBER (1985) On the effect of calcium antagonists (nifedipine) on nephrocalcinosis and calcium excretion in the rat Urol.Int. 40, 13-21
  3. ↑ WLSTROHMAIER, D.SEEGER, H.OSSWALD, K.-H.BICHLER (1992) Renal insufficiency induced by parathyroid hormone - influence of the calcium antagonist Gö 6070 Eur. Urol. 21, 323 - 327
  4. ↑ WLSTROHMAIER, B.WITTE, HJNELDE (1994) Influence of nifedipine on stone formation and renal function in cholesterol-induced nephrolithiasis in rats Urol. Int. 52: 87-92
  5. ↑ WLSTROHMAIER, RDSEEGER, H.OSSWALD, K.-H.BICHLER (1994) Reduction of vitamin D induced stone formation by calcium antagonists. Urol. Res. 22: 301-303
  6. ↑ WLSTROHMAIER (2000) Course of calcium stone disease without treatment. What can we expect? Eur. Urol. 37: 339-344
  7. ↑ WLSTROHMAIER, J.SCHMIDT, S.LAHME, K .-. BICHLER (2000) Arterial blood pressure following different types of stone therapy Eur. Urol. 38: 753-757
  8. ↑ WLSTROHMAIER, J.SEILNACHT, G.SCHUBERT (2012) Urinary stone formers with hypocitraturia and 'normal' urinary pH are at high risk for recurrence. Urol Int 88: 294-297
  9. ↑ WLSTROHMAIER (2017) Infection induced urinary stones. In: Bjerklund Johansen TE, Wagenlehner FME, Matsumoto T, Cho YH, Krieger JN, Shoskes D, Naber KG, editors. Urogenital Infections and Inflammations. Duesseldorf: GMS; 2017-.DOI: 10.5680 / lhuii000017
  10. ↑ WLSTROHMAIER, M.HÖRMANN, G.SCHUBERT (2013) Papillary calcifications: a new prognostic factor in idiopathic calcium oxalate urolithiasis Urolithiasis 41: 475-479
  11. ↑ WLSTROHMAIER, BMWROBEL, G. SCHUBERT (2012) Overweight, insulin resistance and blood pressure (parameters of the metabolic syndrome) in uric acid urolithiasis. Urol Res 40: 171-175
  12. ↑ BMWROBEL, G.SCHUBERT, M.HÖRMANN, WLSTROHMAIER (2012) Overweight and Obesity: Risk Factors in Calcium Oxalate Stone Disease? Advances Urol 2012 Article ID 438707, 4 pages
  13. ↑ WLSTROHMAIER (2016) Recent advances in understanding and managing urolithiasis F1000 Research 5: (F1000 Faculty Rev): 2651
  14. ↑ WLSTROHMAIER, K.-H.BICHLER, P.DEETJEN, S.KLEINKNECHT, M.PEDRO, DMWILBERT (1990) Damaging effects of high energy shock waves on cultured Madine Darby Canine Kidney (MDCK) cells. Urol. Res. 18, 255-258
  15. ↑ WLSTROHMAIER, K.-H.BICHLER, J.KOCH, N.BALK, DMWILBERT (1993) Protective effect of verapamil on shock wave induced renal tubular dysfunction. J. Urol. 150: 27-29
  16. ↑ WLSTROHMAIER, J.KOCH, N.BALK, DMWILBERT, K.-H.BICHLER (1994) Limitation of shock-wave-induced renal tubular dysfunction by nifedipine. Eur. Urol. 25: 99-104
  17. ↑ WLSTROHMAIER, G.SCHUBERT, T.ROSENKRANZ, A.WEIGL, (1999) Comparison of extracorporeal shock wave lithotripsy and ureteroscopy in the treatment of ureteral calculi: a prospective study. Eur. Urol. 36: 376-379
  18. ↑ S.LAHME, K.-H.BICHLER, WLSTROHMAIER, T. GÖTZ (2001) Minimally invasive PCNL in patients with renal pelvic and calyceal stones. Eur Urol 40: 619-624
  19. ↑ WLSTROHMAIER, A. GIESE (2001) Porcine urinary tract as a training model for ureteroscopy. Urol. Int. 66: 30-32
  20. ↑ WLSTROHMAIER, A. GIESE (2005) Ex vivo training model for percutaneous renal surgery. Urol. Res. 33: 191-193
  21. ↑ WLSTROHMAIER, A. GIESE (2009) Improved ex vivo training model for percutaneous renal surgery. Urol Res 37: 107-110
  22. ↑ WLSTROHMAIER (2000) Economic Aspects of Urinary Stone Suffering and Urinary Stone Metaphylaxis
  23. ↑ WLSTROHMAIER (2006) Economic Aspects of Evidence-Based Urinary Stone Metaphylaxis. Urologist 45: 1406-1409
  24. ↑ W..L.STROHMAIER (2012) Economics of stone disease / treatment. Arab J Urol 10: 273-278
  25. ↑ WLSTROHMAIER, K.-H.BICHLER, SHFLÜCHTER, DMWILBERT (1990) Microwave Hyperthermia of Benign Prostatic Hyperplasia. J. Urol. 144, 913-917
  26. ↑ WLSTROHMAIER, K.-H.BICHLER, A.BÖCKING, SHFLÜCHTER (1991) Histological effects of local microwave hyperthermia in prostatic cancer. Int. J. Hyperth. 7, 27-33
  27. ↑ WLSTROHMAIER, SHFLÜCHTER, DMWILBERT, K.-H.BICHLER (1993) Influence of transrectal hyperthermia on prostate-specific antigen in prostatic cancer and benign prostatic hyperplasia. Urol. Int. 51: 28-31
  28. ↑ WLSTROHMAIER, A.ZUMBRÄGEL, L.KOSCHELLA, KHBICHLER (1997) Is the determination of prostatic acid phosphatase (PAP) still worthwhile in prostate cancer patients? J. Urol. Oncol. 3: 47-50
  29. ↑ WLSTROHMAIER, T.KELLER, K.-H.BICHLER (1999) Follow-up in prostate cancer patients: which parameters are necessary? Eur. Urol. 35: 21-25
  30. ↑ WLSTROHMAIER (2002) PSA - biological influencing variables, 1-15 in: P. Fornara, A.Semjonow (ed.): PSA: The way to the diagnosis Zuckschwert Germering
  31. ↑ WLSTROHMAIER, K.-H.BICHLER, F.SCHANZ (1986) Immunodiagnostically flanked interferon therapy in metastatic hypernephroid carcinoma. Helv.Chir.Acta 53, 317-319
  32. ↑ K.-H.BICHLER, S.KLEINKNECHT, WLSTROHMAIER (1990) Immune Status and Immune Therapy of Renal Cell Carcinoma. Urol. Int. 45, 269-283
  33. ↑ S.KLEINKNECHT, K.-H.BICHLER, WLSTROHMAIER (1992) Postoperative long-term course of peripheral blood immune parameters and immunomodulating effects of keyhole limpet hemocyanine (KLH) in patients with non-metastatic renal cell carcinoma. Eur. Urol. 21, 315 - 321
  34. ↑ WLSTROHMAIER (1999) [Renal Cancer] New treatment modalities - the urologist's view. Anticancer Res. 19: 1605-1610
personal data
SURNAME Strohmaier, Walter Ludwig
BRIEF DESCRIPTION German urologist
DATE OF BIRTH May 27, 1957
PLACE OF BIRTH Stuttgart